ELI LILLY & Co — Director's Dealing 2025

Aug 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-08-12

Reporting Person: Fyrwald J Erik (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-12	Common Stock	P	686	$641.996	Acquired	73698.779	Direct
2025-08-12	Common Stock	P	879	$642.586	Acquired	74577.779	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.